Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodney J Ellis

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Expert Review of Anticancer Therapy|March 22, 2016
Stereotactic body radiotherapy for pancreatic cancer: recent progress and future directionsSten Myrehaug, Arjun Sahgal, Suzanne M Russo, et al.
IEEE Access : Practical Innovations, Open Solutions|March 22, 2021
Synthetic CT Generation of the Pelvis in Patients With Cervical Cancer: A Single Input Approach Using Generative Adversarial NetworkAtallah Baydoun, K E Xu, Jin Uk Heo, et al.
International Journal of Radiation Oncology, Biology, Physics|June 21, 2020
Stereotactic Ablative Radiotherapy for ≥T1b Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK)Shankar Siva, Rohann J M Correa, Andrew Warner, et al.
Medical Physics|May 8, 2019
UTE-mDixon-based thorax synthetic CT generationKuan-Hao Su, Harry T Friel, Jung-Wen Kuo, et al.
International Journal of Radiation Oncology, Biology, Physics|January 14, 2014
Outcomes in a multi-institutional cohort of patients treated with intraoperative radiation therapy for advanced or recurrent renal cell carcinomaJonathan J Paly, Christopher L Hallemeier, Peter J Biggs, et al.
The Lancet. Oncology|November 18, 2022
5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney)Shankar Siva, Muhammad Ali, Rohann J M Correa, et al.
European Urology Oncology|July 10, 2024
Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the KidneyVivian S Tan, Rohann J M Correa, Andrew Warner, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 9, 2025
Assessing Quality and Adherence to PI-RADSv2.1 Minimum Technical Standards of Prostate MRI in NRG-GU005Stephanie Alley, Marion Tonneau, Damien Olivié, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2023
Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized TrialBenjamin Movsas, Joseph P Rodgers, Mohamed A Elshaikh, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Expert Review of Anticancer Therapy|March 22, 2016
Stereotactic body radiotherapy for pancreatic cancer: recent progress and future directionsSten Myrehaug, Arjun Sahgal, Suzanne M Russo, et al.
IEEE Access : Practical Innovations, Open Solutions|March 22, 2021
Synthetic CT Generation of the Pelvis in Patients With Cervical Cancer: A Single Input Approach Using Generative Adversarial NetworkAtallah Baydoun, K E Xu, Jin Uk Heo, et al.
International Journal of Radiation Oncology, Biology, Physics|June 21, 2020
Stereotactic Ablative Radiotherapy for ≥T1b Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK)Shankar Siva, Rohann J M Correa, Andrew Warner, et al.
Medical Physics|May 8, 2019
UTE-mDixon-based thorax synthetic CT generationKuan-Hao Su, Harry T Friel, Jung-Wen Kuo, et al.
International Journal of Radiation Oncology, Biology, Physics|January 14, 2014
Outcomes in a multi-institutional cohort of patients treated with intraoperative radiation therapy for advanced or recurrent renal cell carcinomaJonathan J Paly, Christopher L Hallemeier, Peter J Biggs, et al.
The Lancet. Oncology|November 18, 2022
5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney)Shankar Siva, Muhammad Ali, Rohann J M Correa, et al.
European Urology Oncology|July 10, 2024
Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the KidneyVivian S Tan, Rohann J M Correa, Andrew Warner, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 9, 2025
Assessing Quality and Adherence to PI-RADSv2.1 Minimum Technical Standards of Prostate MRI in NRG-GU005Stephanie Alley, Marion Tonneau, Damien Olivié, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2023
Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized TrialBenjamin Movsas, Joseph P Rodgers, Mohamed A Elshaikh, et al.
Pageof 5